Discovery of a novel and potent, and urea isostere inhibitors series of dianilinopyrimidineurea of VEGFR2 tyrosine kinase

被引：33

作者：

Sammond, DM ^{[1
]}

Nallor, KE ^{[1
]}

Veal, JM ^{[1
]}

Nolte, RT ^{[1
]}

Wang, LP ^{[1
]}

Knick, VB ^{[1
]}

Rudolph, SK ^{[1
]}

Truesdale, AT ^{[1
]}

Nartey, EN ^{[1
]}

Stafford, JA ^{[1
]}

Kumar, R ^{[1
]}

Cheung, M ^{[1
]}

机构：

[1] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 15期

关键词：

VEGFR2; FLK-1; KDR; kinase inhibitor;

D O I：

10.1016/j.bmcl.2005.05.096

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：3519 / 3523

页数：5

共 50 条

[31] Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
Jiang, Zongru
Wang, Li
Liu, Xuesong
Chen, Cheng
Wang, Beilei
Wang, Wenliang
Hu, Chen
Yu, Kailin
Qi, Ziping
Liu, Qingwang
Wang, Aoli
Liu, Jing
Hong, Guangchen
Wang, Wenchao
Liu, Qingsong
ACTA PHARMACEUTICA SINICA B, 2020, 10 (03) : 488 - 497
[32] Design and discovery of new selective and potent VEGF receptor 2 tyrosine kinase inhibitors
Hou, Fei
Yao, Yuhong
Wei, Yujiao
Wang, Yubo
Cao, Yangzi
Liu, Xinqiang
Zheng, Liting
Zhang, Qingqing
Jiao, Yue
Chen, Yukun
Meng, Yue
Sun, Yue
Wu, Yanjie
Wang, Jiefu
Wang, Junfeng
Wu, Zhou
Zhang, Kun
Wei, Mingming
Yang, Guang
BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 91
[33] Discovery of a Novel Series of Potent SHP2 Allosteric Inhibitors
Petrocchi, Alessia
Grillo, Alessandro
Ferrante, Luca
Randazzo, Pietro
Prandi, Adolfo
De Matteo, Marilenia
Iaccarino, Costanza
Bisbocci, Monica
Cellucci, Antonella
Alli, Cristina
Nibbio, Martina
Pucci, Vincenzo
Amaudrut, Jerome
Montalbetti, Christian
Toniatti, Carlo
Di Fabio, Romano
ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (05): : 645 - 651
[34] Discovery of novel selective spleen tyrosine kinase inhibitors
Northrup, Alan B.
Altman, Michael D.
Andresen, Brian M.
Anthony, Neville J.
Arrington, Kenneth L.
Bhat, Sathesh
Bienstock, Corey E.
Black, Cameron
Burch, Jason
Butcher, John W.
Childers, Kaleen Konrad
Cote, Bernard
Deschenes, Denis
di Francesco, Emilia
Donofrio, Anthony
Ducharme, Yves
Dupont-Gaudet, Kristina
Ellis, J. Michael
Fischer, Christian
Fournier, Jean-Francois
Friesen, Rick
Gauthier, Jacques Yves
Grimm, Jonathan B.
Guay, Daniel
Guerin, David J.
Haidle, Andrew M.
Jewell, James P.
Kattar, Solomon D.
Li, Chaomin
Lim, Jongwon
Lee, Sandra
Liu, Yuan
Machacek, Michelle R.
Maddess, Matthew L.
Miller, Thomas A.
O'Boyle, Brendan M.
Otte, Ryan D.
Peterson, Scott L.
Petrocchi, Alessia
Reutershan, Michael H.
Romeo, Eric T.
Robichaud, Joel S.
Schell, Adam J.
Siu, Tony
Smith, Graham F.
Spencer, Kerrie B.
Taoka, Brandon M.
Trotter, B. Wesley
Yang, Liping
Woo, Hyun Chong
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
[35] Discovery of potent and selective reversible Bruton?s tyrosine kinase inhibitors
Qiu, Hui
Ali, Zahid
Bender, Andrew
Caldwell, Richard
Chen, Yi-Ying
Fang, Zhizhou
Gardberg, Anna
Glaser, Nina
Goettsche, Anja
Goutopoulos, Andreas
Grenningloh, Roland
Hanschke, Bettina
Head, Jared
Johnson, Theresa
Jones, Christopher
Jones, Reinaldo
Kulkarni, Shashank
Maurer, Christine
Morandi, Federica
Neagu, Constantin
Poetzsch, Sven
Potnick, Justin
Schmidt, Ralf
Roe, Katherine
Follis, Ariele Viacava
Wing, Carolyn
Zhu, Xiaohua
Sherer, Brian
BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 40
[36] Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors
Zhao, Zhiqiang
Pissarnitski, Dmitri A.
Josien, Hubert B.
Wu, Wen-Lian
Xu, Ruo
Li, Hongmei
Clader, John W.
Burnett, Duane A.
Terracina, Giuseppe
Hyde, Lynn
Lee, Julie
Song, Lixin
Zhang, Lili
Parker, Eric M.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (22) : 8806 - 8817
[37] Structure-Activity Relationship Studies on VEGFR2 Tyrosine Kinase Inhibitors for Identification of Potential Natural Anticancer Compounds
Verma, Meenakshi
Sarfraz, Aqib
Hasan, Inamul
Vasudev, Prema Gauri
Khan, Feroz
MEDICINAL CHEMISTRY, 2024, 20 (06) : 646 - 661
[38] Discovery of indazolylpyrimidine GW786034 as a potent pan VEGFR tyrosine kinase inhibitor.
Cheung, M
Baloor, A
Chamberlain, SD
Hinkle, KW
Davis-Ward, RG
Harris, PA
Laudeman, CP
Mook, RA
Nailor, KE
Szewczyk, GR
Veal, JM
McGuire, MA
Truesdale, AT
Johnson, JH
Crosby, RM
Knick, VB
Rudolph, SK
Epperly, AH
Kumar, R
Mullin, RJ
Gilmer, TM
Luttrell, DK
Stafford, JA
CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9109S - 9109S
[39] Discovery and SAR of novel [1,6]naphthyridines as potent inhibitors of Spleen Tyrosine Kinase (SYK)
Cywin, CL
Zhao, BP
McNeil, DW
Hrapchak, M
Prokopowicz, AS
Goldberg, DR
Morwick, TM
Gao, A
Jakes, S
Kashem, M
Magolda, RL
Soll, RM
Player, MR
Bobko, MA
Rinker, J
DesJarlais, RL
Winters, MP
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (08) : 1415 - 1418
[40] Novel Substituted Quinazolines for Potent EGFR Tyrosine Kinase Inhibitors
Cruz-Lopez, O.
Conejo-Garcia, A.
Nunez, M. C.
Kimatrai, M.
Garcia-Rubino, M. E.
Morales, F.
Gomez-Perez, V.
Campos, J. M.
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (07) : 943 - 963

← 1 2 3 4 5 →